# Static Lung Hyperinflation and Sympathetic Nerve Activity-Associated Large Artery Stiffness in COPD Patients

> **NCT03611699** · PHASE4 · COMPLETED · sponsor: **Gary L. Pierce** · enrollment: 15 (actual)

## Conditions studied

- COPD

## Interventions

- **DRUG:** Umeclidinium / Vilanterol Dry Powder Inhaler
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03611699
- **Lead sponsor:** Gary L. Pierce
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-01-24
- **Primary completion:** 2020-04-01
- **Final completion:** 2020-04-01
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2020-07-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03611699

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03611699, "Static Lung Hyperinflation and Sympathetic Nerve Activity-Associated Large Artery Stiffness in COPD Patients". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT03611699. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*